Cambridge Biomedical Announces Implementation of LabVantage LIMS System

Share Article

Cambridge Biomedical has a continual commitment to Quality and continuous improvement and as part of that we have committed to implementing a best-in-class Laboratory Information Management System.

This marks a milestone on our continuing commitment to providing our clients Best-In-Class service and our continual commitment to Quality

Cambridge Biomedical announces the implementation of LabVantage Laboratory Information Management System (LIMS)

Cambridge Biomedical has a continual commitment to Quality and continuous improvement and as part of that we have committed to implementing a best-in-class Laboratory Information Management System.

After an extensive investigation of LIMS systems suitable for both Clinical Diagnostic and Clinical Research aspects of their business they have entered into an agreement to implement LabVantage with a targeted launch in Spring 2016.

“This marks a milestone on our continuing commitment to providing our clients Best-In-Class service and our continual commitment to Quality” said Anthony Davis, Director of Quality Assurance “and I am proud to be the project leader on this endeavour and excited by the tremendous opportunities this will bring to organization”.

About Cambridge Biomedical

Cambridge Biomedical, based in Boston, Massachusetts, supports sponsors by developing customized assays for small and large molecules, biomarkers, and other critical analytes, along with validation and sample testing in our CLIA certified and CAP accredited, GLP/GCLP compliant facilities,

The Company has extensive expertise in technology transfer, assay development, optimization and validation. It also offers specific services in analytical support for PK/PD studies, biomarker development, clinical assay development, assay validation, specimen analysis, and testing services in support of clinical trial and drug or device development.

Our personalized project methodology, along with a focus on delivering quality results and regulatory submission ready documentation and rapid turnaround times, ensures we meet our client’s product development timelines.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bob Evans
Cambridge Biomedical Inc.

Follow us on
Visit website